Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Viridian Therapeutics Inc (NQ: VRDN ) 22.84 +0.56 (+2.51%) Streaming Delayed Price Updated: 4:00 PM EST, Nov 4, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Viridian Therapeutics Inc < Previous 1 2 3 4 5 6 Next > Viridian Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) May 03, 2024 From Viridian Therapeutics, Inc. Via Business Wire Viridian Therapeutics to Webcast First Quarter 2024 Financial Results on May 8, 2024 April 29, 2024 From Viridian Therapeutics, Inc. Via Business Wire Viridian Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) April 04, 2024 From Viridian Therapeutics, Inc. Via Business Wire Unveiling 4 Analyst Insights On Viridian Therapeutics March 20, 2024 Via Benzinga Navigating 6 Analyst Ratings For Viridian Therapeutics February 28, 2024 Via Benzinga Analyst Ratings for Viridian Therapeutics December 04, 2023 Via Benzinga Finding the Next Big Winners: 3 Stocks You Can Snag for Under $20 March 19, 2024 Although cheap stocks under $20 represent a higher-risk profile, the rewards could be massive if the spotlight shines on them. Via InvestorPlace Viridian Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) March 06, 2024 From Viridian Therapeutics, Inc. Via Business Wire Viridian Therapeutics to Participate in the Leerink Partners Global Biopharma Conference March 05, 2024 From Viridian Therapeutics, Inc. Via Business Wire Viridian Therapeutics Highlights Recent Progress and Reports Fourth Quarter and Full Year 2023 Financial Results February 27, 2024 From Viridian Therapeutics, Inc. Via Business Wire Where Viridian Therapeutics Stands With Analysts November 14, 2023 Via Benzinga Viridian Therapeutics Appoints Jennifer Tousignant as Chief Legal Officer February 16, 2024 From Viridian Therapeutics, Inc. Via Business Wire Viridian Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) February 06, 2024 From Viridian Therapeutics, Inc. Via Business Wire Here's Why Viridian Therapeutics (VRDN) Stock Is Moving January 18, 2024 Viridian Therapeutics shares are trading lower by 5.9% Thursday morning. The company announced pricing of an underwritten public offering. Via Benzinga Viridian Therapeutics Announces Pricing of Public Offering of Shares of Common Stock January 17, 2024 From Viridian Therapeutics, Inc. Via Business Wire Viridian Therapeutics Announces Proposed Underwritten Public Offering of Common Stock and Preferred Stock January 17, 2024 From Viridian Therapeutics, Inc. Via Business Wire Viridian Therapeutics to Present Key 2024 Corporate Priorities at J.P. Morgan Healthcare Conference January 08, 2024 From Viridian Therapeutics, Inc. Via Business Wire Viridian Therapeutics to Webcast Presentation at the 42nd Annual J.P. Morgan Healthcare Conference January 04, 2024 From Viridian Therapeutics, Inc. Via Business Wire ZimVie Agrees To Sell Its Spine Business, Joins United States Steel, PGT Innovations And Other Big Stocks Moving Higher On Monday December 18, 2023 U.S. stocks traded mostly higher, with the Nasdaq Composite gaining around 30 points on Monday. Via Benzinga Topics Stocks Exposures US Equities Viridian Therapeutics Announces Positive Clinical Data in Healthy Volunteer Study and Selects VRDN-003 as Potential Best-in-Class Subcutaneous anti-IGF-1R Program with Extended Half-Life for Pivotal Development in Thyroid Eye Disease December 18, 2023 From Viridian Therapeutics, Inc. Via Business Wire Viridian Therapeutics to Participate in 6th Annual Evercore ISI HealthCONx Conference November 21, 2023 From Viridian Therapeutics, Inc. Via Business Wire Viridian Therapeutics Reports Third Quarter 2023 Financial Results and Provides Corporate Update November 13, 2023 From Viridian Therapeutics, Inc. Via Business Wire Viridian Therapeutics to Participate in the Jefferies London Healthcare Conference November 08, 2023 From Viridian Therapeutics, Inc. Via Business Wire Viridian Therapeutics Announces Encore Presentations at the 2023 Annual Meeting of the American Academy of Ophthalmology November 03, 2023 From Viridian Therapeutics, Inc. Via Business Wire Western Digital, JinkoSolar, Lumentum Holdings And Other Big Stocks Moving Higher On Monday October 30, 2023 U.S. stocks traded higher, with the Nasdaq Composite gaining more than 100 points on Monday. Here are some big stocks recording gains in today’s session. Via Benzinga Topics Stocks Exposures US Equities Viridian Therapeutics Appoints New Chief Executive Officer, Unveils Next Generation FcRn Inhibitor Programs and Announces $185 Million Private Placement Financing October 30, 2023 From Viridian Therapeutics, Inc. Via Business Wire Viridian Therapeutics Enters Autoinjector Pen Device Customization and Supply Agreement with Ypsomed AG for Subcutaneous Drug Delivery in Thyroid Eye Disease October 26, 2023 From Viridian Therapeutics, Inc. Via Business Wire Stocks That Hit 52-Week Lows On Tuesday October 03, 2023 On Tuesday, 647 companies set new 52-week lows. Via Benzinga Stocks That Hit 52-Week Lows On Thursday September 28, 2023 During Thursday's session, 406 companies made new 52-week lows. Via Benzinga Stocks That Hit 52-Week Lows On Tuesday September 26, 2023 On Tuesday, 386 stocks made new 52-week lows. Via Benzinga < Previous 1 2 3 4 5 6 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
